The FDA has launched a safety study of the abortion pill, also known as mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and used, the Wall Street Journal reported on Thursday, News.az reports, citing Reuters.
The FDA study, using existing drug-safety systems, is expected to take six months and aims to withstand legal criticism, the report said, citing administration officials.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。